VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were up 17.2% during trading on Wednesday . The company traded as high as C$0.17 and last traded at C$0.17. Approximately 126,000 shares were traded during trading, a decline of 57% from the average daily volume of 290,886 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Trading Up 13.8 %
The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The stock has a market cap of C$26.76 million, a P/E ratio of -5.10 and a beta of 0.39. The firm’s fifty day moving average price is C$0.10 and its two-hundred day moving average price is C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to Find Undervalued Stocks
- Why Energy Transfer Belongs on Your Watchlist
- 5 Top Rated Dividend Stocks to Consider
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
